JIANGSU HUALAN NEW PHARMACEUTICAL MATERIAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.72 CNY | +0.98% |
|
-2.32% | -29.66% |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's profit outlook over the next few years is a strong asset.
- The company returns high margins, thereby supporting business profitability.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Ratings chart - Surperformance
Sector: Tires & Rubber Products
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -29.66% | 404M | - | ||
| +18.51% | 30.49B | A- | ||
| +14.91% | 28.99B | A | ||
| +34.38% | 6.89B | C | ||
| +27.56% | 4.26B | B+ | ||
| -9.57% | 3.69B | B- | ||
| +57.31% | 3.64B | - | - | |
| +19.91% | 3.11B | B- | ||
| +16.18% | 2.71B | B | ||
| +15.68% | 2.7B | C- |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 301093 Stock
- Ratings Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
